Oncology Pharmacy Residency
In 2023, the medical center graduated its inaugural Oncology Pharmacy Residency class of two students. Additionally, the program obtained national accreditation from the American Society of Health-System Pharmacists. An oncology pharmacy residency provides licensed postgraduate pharmacists advanced clinical training that is more focused and rigorous than typical professional practice. Members of the inaugural class, Natalie Hurst, PharmD, BCOP and Ashley Mull, PharmD, BCOP, have become integral members of the Cancer Insitute’s pharmacy team, obtaining oncology pharmacy board certification and remaining part of the team after graduation. The Oncology Pharmacy Residency program relies heavily on oncology pharmacists, oncologists, advanced practice providers and nurses dedicated to teaching during clinical practice. Oncology pharmacy residents at the medical center provide patient care not only in the same settings as oncology pharmacists, but they also practice within physician ambulatory clinics, allowing for more face-to-face patient interaction. Integration of resident pharmacists in the clinic has increased efficiency of patient care between CI physician offices and the infusion centers. It has also provided patients access to the same level of oncology pharmacist care for those receiving oral cancer medications in the ambulatory setting. The Oncology Pharmacy team sincerely appreciates the Cancer Institute’s practitioners and nurses for their important contributions to the Oncology Pharmacy Residency program.
Natalie Hurst, PharmD, BCOP
Ashley Mull, PharmD, BCOP
| Cancer Institute Annual Report 20
Made with FlippingBook interactive PDF creator